UK quoted biotech performance and investor base in 2020

This report is an exclusive analysis of the performance of the UK-quoted biotech sector and the breadth of its investor base by Radnor Capital Partners on behalf of the BIA.

During 2020, biotech companies on the London Stock Exchange's AIM and Main Market out-performed the FTSE All-Share by over 150%, raised over £1bn in fresh equity capital, and attracted 69 institutional investors, including 24 new US finance houses.